Skip Navigation LinksHome > May 2007 - Volume 26 - Issue 5 > Use of Meningococcal Vaccines in the United States
Pediatric Infectious Disease Journal:
doi: 10.1097/01.inf.0000259996.95965.ef
CDC Review Article

Use of Meningococcal Vaccines in the United States

Bilukha, Oleg MD; Messonnier, Nancy MD; Fischer, Marc MD

Collapse Box

Abstract

In January 2005, Food and Drug Administration licensed a new tetravalent (serogroups A, C, Y, W-135) meningococcal conjugate vaccine ([MCV4] Menactra) for use in persons 11–55 years of age. In February 2005, CDC's Advisory Committee on Immunization Practices (ACIP) recommended routine vaccination of adolescents and college freshmen living in dormitories with MCV4. The manufacturer started shipments of MCV4 in March 2005. MCV4 should become a key addition to existing meningococcal disease prevention measures.

© 2007 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.